
|Videos|March 25, 2022
Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids
Author(s)Miranda Hester
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
PECOS study identifies 20 post-COVID symptoms in children, from fatigue to cardiac and mental health effects
2
FAQ: What does the new "faltering weight" guideline mean for your practice?
3
RSV Prevention and Vaccine Hesitancy: Building Long-Term Communication
4
Pertussis resurgence: An expert Q&A on diagnostic delays and point-of-care testing
5




